Table 3.
Comparison of Actual Lipase Activity to Label Claim in Various Pancreatic Enzyme Products
| Product | Label Claim (Activity per Capsule) | Activity Found (Activity per Capsule) | % Label Claim |
|---|---|---|---|
| Creon® 10,000 | 10,000 EP units | 12,031 EP units | 120 |
| Creon® 25,000 | 25,000 EP units | 27,661 EP units | 111 |
| Creon® 40,000 | 40,000 EP units | 41,654 EP units | 104 |
| Agna™ 10,000 | 10,000 EP units | 6,748 EP units | 67 |
| Agna™ 25,000 | 25,000 EP units | 19,217 EP units | 77 |
| Enzar™ 10,000 | 10,000 EP units | 8178 EP units | 82 |
| Enzar™ HS | 25,000 EP units | 23,320 EP units | 93 |
| Enzar™ 40,000 | 40,000 EP units | 43,221 EP units | 108 |
| Panlipase® 10,000 | 10,000 USP units | 7943 USP units | 79 |
| Panlipase® 25,000 | 25,000 USP units | 13,760 USP units | 55 |
Abbreviations: EP, European pharmacopoeia; USP, United States pharmacopoeia.